Viking Therapeutics, Inc. (Viking) (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the ...
A large new analysis suggests that many people with normal weight may still carry health risks that traditional measures fail ...
UPFs now make up 50 per cent of the average diet in the UK - and have been linked to cancer, heart attacks and early death ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback